Literature DB >> 11738188

Evoked potentials for evaluation of multiple sclerosis.

P Fuhr1, L Kappos.   

Abstract

The role of evoked potentials (EP) in the assessment of multiple sclerosis (MS) has changed over the last decade. This is largely due to progress in imaging techniques. But while MRI has a greater diagnostic sensitivity, EP remain a useful diagnostic tool in many clinical situations. Moreover, recent studies demonstrate the utility of EP for monitoring and predicting the course of the disease in patient groups, although not yet in individuals. For these purposes, EP show better results than conventional MRI. In the near future, new developments in electrophysiology, immunology and imaging may allow to differentiate between different subtypes of MS early in the course, and consequently to tailor therapeutic measures more precisely to the individual patients.

Entities:  

Mesh:

Year:  2001        PMID: 11738188     DOI: 10.1016/s1388-2457(01)00687-3

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  13 in total

1.  Relationship between thiol-disulphide homeostasis and visual evoked potentials in patients with multiple sclerosis.

Authors:  Gönül Vural; Şadiye Gümüşyayla; Orhan Deniz; Salim Neşelioğlu; Özcan Erel
Journal:  Neurol Sci       Date:  2018-12-01       Impact factor: 3.307

2.  Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  A Conte; D Lenzi; V Frasca; F Gilio; E Giacomelli; M Gabriele; C Marini Bettolo; E Iacovelli; P Pantano; C Pozzilli; M Inghilleri
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

3.  Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis.

Authors:  J L Neva; B Lakhani; K E Brown; K P Wadden; C S Mang; N H M Ledwell; M R Borich; I M Vavasour; C Laule; A L Traboulsee; A L MacKay; L A Boyd
Journal:  Behav Brain Res       Date:  2015-10-20       Impact factor: 3.332

4.  Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis.

Authors:  Gençer Genç; Şeref Demirkaya; Semai Bek; Zeki Odabaşi
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

5.  Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities.

Authors:  Andrea Gagliardo; Francesca Galli; Antonello Grippo; Aldo Amantini; Cristiana Martinelli; Maria Pia Amato; Walter Borsini
Journal:  J Neurol       Date:  2007-02-17       Impact factor: 4.849

6.  Educational Case: Multiple sclerosis.

Authors:  Ariana Pape; Laurie L Wellman; Richard M Conran
Journal:  Acad Pathol       Date:  2022-07-08

7.  Differential cognitive impairment for diverse forms of multiple sclerosis.

Authors:  Javier J Gonzalez-Rosa; Manuel Vazquez-Marrufo; Encarnacion Vaquero; Pablo Duque; Monica Borges; Miguel A Gamero; Carlos M Gomez; Guillermo Izquierdo
Journal:  BMC Neurosci       Date:  2006-05-19       Impact factor: 3.288

8.  Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?

Authors:  Nicolò Margaritella; Laura Mendozzi; Massimo Garegnani; Raffaello Nemni; Elena Colicino; Elisabetta Gilardi; Luigi Pugnetti
Journal:  BMC Neurol       Date:  2012-08-22       Impact factor: 2.474

9.  Comparison of neurophysiological and MRI findings of patients with multiple sclerosis using oligoclonal band technique.

Authors:  Hamit Y Ellidag; Esin Eren; Nezahat Erdogan; Sabiha Ture; Necat Yilmaz
Journal:  Ann Neurosci       Date:  2013-10

10.  Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression.

Authors:  Liesbet M Peeters; Marjan Vanheusden; Veerle Somers; Bart Van Wijmeersch; Piet Stinissen; Bieke Broux; Niels Hellings
Journal:  Front Immunol       Date:  2017-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.